欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0867/002
药品名称
Beta-histina Aurobindo
活性成分
betahistine hydrochloride 16.0 mg
剂型
Tablet
上市许可持有人
Aurobindo Pharma (Portugal), Unipessoal Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Bulgaria (BG)
Betahistine Aurobindo
Netherlands (NL)
Ireland (IE)
Spain (ES)
Italy (IT)
Poland (PL)
Behistep
Romania (RO)
Betahistina diclorhidrat Aurobindo 16 mg comprimate
Malta (MT)
Betahistine 16 mg tablets
许可日期
2014/07/10
最近更新日期
2024/08/13
药物ATC编码
N07CA01 betahistine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase